Data / Form D filings / KisoTerra Biotech Corp.
KisoTerra Biotech Corp.: Form D filings
KisoTerra Biotech Corp., a company in Vancouver, British Columbia, Canada, filed 7 Form D notices with the SEC between 2018 and 2025. The latest, on February 5, 2025, reports $24,165 sold of a $24,165 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1090 HOMER STREET, SUITE 300, Vancouver, British Columbia, Canada, V6B 2
- Phone
- (604) 260-6944
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1754473
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | New notice | $24,165 | $24,165 | 1 | Jan 31, 2025 | sec.gov | |
| Jan 22, 2025 | New notice | $250,000 | $250,000 | 3 | Jan 14, 2025 | sec.gov | |
| May 30, 2024 | New notice | $10,000 | $10,000 | 1 | May 23, 2024 | sec.gov | |
| Jul 7, 2021 | New notice | $3,725,000 | $3,725,000 | 12 | Jun 25, 2021 | sec.gov | |
| Nov 2, 2020 | New notice | $210,000 | $210,000 | 2 | Oct 19, 2020 | sec.gov | |
| Mar 27, 2019 | New notice | $20,000 | $20,000 | 1 | Mar 13, 2019 | sec.gov | |
| Nov 15, 2018 | New notice | $13,734 | $13,734 | 3 | Oct 31, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Josef Reschreiter | Executive Officer, Director | |
| Rich Frontain | Director | |
| David Work | Director | |
| Michael Stocker | Director | |
| Neil Branda | Executive Officer, Director | |
| Dirk Lange | Executive Officer | |
| Brent Hunter | Executive Officer | |
| Douglas Frankiw | Director |
Every Form D from the week of Feb 3, 2025 · All recent Other filings
Read from SEC EDGAR. Amount sold is what KisoTerra Biotech Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.